Printer Friendly

IMMUNEX ELECTS TOM ALBERG DIRECTOR

 IMMUNEX ELECTS TOM ALBERG DIRECTOR
 SEATTLE, July 15 /PRNewswire/ -- Immunex Corp. (NASDAQ: IMNX)


announced today the election of Tom A. Alberg as director, increasing board membership to eight. Alberg is currently president and a director of LIN Broadcasting Corp. and executive vice president of McCaw Cellular Communications Inc.
 "Tom Alberg provided invaluable assistance as outside counsel during our formative years," said Immunex Chairman Stephen A. Duzan. "We welcome his advice and guidance as a director as Immunex enters its next phase of growth and development."
 Alberg was formerly chairman of the executive committee and a partner of Perkins Coie, the largest law firm headquartered in the Pacific Northwest. He is a past chairman of the Pacific Science Center in Seattle and a graduate of Harvard College and Columbia Law School.
 Immunex Corp. is a biopharmaceutical company focused on the research, development, manufacture and marketing of products to treat cancer and autoimmune disease.
 -0- 7/15/92
 /CONTACT: Jason Rubin or Mary McConnon of Immunex, 206-587-0430/
 (IMNX) CO: Immunex Corp. ST: Washington IN: MTC SU: PER


SC-LM -- SE003 -- 9524 07/15/92 12:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 15, 1992
Words:184
Previous Article:UNIVERSAL FOODS ANNOUNCES THIRD QUARTER EARNINGS
Next Article:ACKERLEY COMMUNICATIONS PLANS TO FORM SPORTS ENTERTAINMENT MARKETING DIVISION
Topics:


Related Articles
IMMUNEX ELECTS TOM MIZELLE VICE PRESIDENT, SALES AND MARKETING
IMMUNEX ISSUES INFORMATION UPDATE TO AVOID PATIENT CONFUSION
CYANAMID AND IMMUNEX FORM NEW BIOPHARMACEUTICAL COMPANY; MERGER APPROVED BY IMMUNEX STOCKHOLDERS
/C O R R E C T I O N -- IMMUNEX/
AMERICAN HOME PRODUCTS CORPORATION STATEMENT REGARDING IMMUNEX
FDA Approves Leukine Liquid as First Liquid, Multi-dose Colony Stimulating Factor (CSF)

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters